Rankings Software, cloud & internet Meta Platforms

Meta Platforms

Software, cloud & internet · United StatesRank 291 of 829Prices 2 Nov 2026Model 1.4

A good business with a real question mark: the price, a crack, or both.

Biggest deductions

  • Multiples vs own history and peers−13
  • Cash flow and capex−8
  • Lawsuits and regulation (children and teens)−5

Strengths

  • Pricing power and broad customer base+3
  • Buybacks+1

How the score is built

From 100 to 69, step by step: points off for the business, the price and the cracks, back for documented strengths, then three data adjustments.

100Start
69Score

Hover or select a step to see what drove it. Steps with findings open them below.

Key numbers

As of 2 Nov 2026. Analyst targets tend to be optimistic; read upside as a hint, not a forecast.

Price
606.73 USD
Median analyst target
850.00 USD
Upside to median
+40.1%
Analysts
62
Target range
629.06 – 1,050 USD
52-week change
−6%
P/E (trailing)
20.7
Forward P/E
18.4
PEG
0.95

Findings

Every deduction and every plus, with its source. Open a step to read them.

Business

Is the company getting stronger, not just bigger? · 3 findings
−9 of −30
  • Margin
    The operating margin fell in Q2 to 31% from 43%, because costs rose 55% (incl. $2.4bn for lawsuits and severance after 8,000 layoffs in May). The TTM margin is 38.1% vs 41.4% (2025) and 42.2% (2024). 2026 cost guidance has been raised to $165–169bn, and analysts expect only +4% EPS in 2026 vs +26% revenue: bigger, not stronger.
    −4
  • ROIC
    ROIC has fallen from 43.9% (2024) to 31.3% (2025) and 25.4% TTM, and ROCE from 28.6% to 22.1%. Capex of $89bn TTM vs depreciation of $22.7bn means depreciation will squeeze returns further in the coming years. Still far above a WACC of 10.5%.
    −3
  • Capital allocation
    Reality Labs lost $4.6bn in Q2 ($4.5bn a year earlier) on revenue of about $2.3bn a year; the loss has been around $18–20bn a year for several years with no improvement.
    −2

Price

Today's multiples against the company's own history and its peers. · 1 finding
−13 of −35
  • Multiples vs own history and peers
    Trailing P/E 27.0 vs 13.6–27.5 in 2021–25 (the 2025 figure was lifted by a one-off tax charge, so the old claim of 'highest in 6 years' does not quite hold); forward P/E 22.2 vs 16.4–24.7, i.e. mid-range; EV/EBITDA 16.8 vs 7.1–17.2, at the top; P/FCF 44.5 vs 16.4–36.1 is the highest ever, and consensus expects negative FCF (−$6.5bn) in 2026. FCF yield 2.25%. Reasonable on earnings, expensive on cash flow.
    −13

Cracks

Cash flow, customers, debt, insiders, guidance and what sits behind the headline numbers. · 5 findings
−20 of −35
  • Cash flow and capex
    FCF in Q2 was only $784m ($8.5bn a year earlier), because capex almost doubled to $31.1bn. 2026 capex guidance is $130–145bn vs operating cash flow of about $130bn TTM, and consensus expects negative FCF for the whole of 2026.
    −8
  • Debt and off-balance-sheet commitments
    From net cash of $28.8bn (2024) to net debt of $22.1bn; $54.8bn of new debt over the last 12 months, and long-term debt is $83.7bn. On top comes the Hyperion data centre ($27bn), which sits off balance sheet in a JV with Blue Owl (80%), but where Meta has given a 16-year residual-value guarantee.
    −4
  • Lawsuits and regulation (children and teens)
    A New Mexico jury ordered Meta to pay $375m in March, and in August Meta became the first social network declared a 'public nuisance' and was ordered to pay $567m into a fund and tighten teen accounts. Meta is appealing. Management itself writes that several youth lawsuits in the US this year 'may ultimately result in a material loss', and Q2 carried $2.4bn of legal and severance costs.
    −5
  • Competition (AI agents)
    The September rally of about 30% rests on the AI agent Muse, which has no revenue yet. The stock fell 4.8% on 28/9 when OpenAI's competing 'o' agent and Meta's own enterprise launch made the market reprice; the share price is 8% below its $779 peak.
    −2
  • Insider trading
    Zuckerberg-related entities (CZI Holdings and Chan Zuckerberg Biohub) sold 27,474 shares for $21.4m at about $777 on 24/9, near the top, under a 10b5-1 plan; continuous selling and no insider buying.
    −1

Plus

Only documented strengths. · 2 findings
+4 of +15
  • Pricing power and broad customer base
    Q2 revenue rose 28% to $60.8bn with both 14% more ad impressions and a 12% higher price per ad; millions of advertisers and 3.6bn daily users. Q3 guidance $61–64bn.
    +3
  • Buybacks
    The share count has fallen 1.1% in a year; buybacks ($21.4bn) and dividends ($5.4bn) TTM are below FCF of $41.0bn. But no shares were bought back in Q2, and with negative FCF ahead, buybacks are effectively debt-funded.
    +1

Caveats

What the score does not capture, or where the data is weak.
Analysts expect negative FCF in 2026 (capex $130–145bn), and EPS grows only about 4% this year despite 26% revenue growth. The share rose about 30% in September on the AI agent Muse, which does not yet make money, and fell 4.8% on 28/9 on OpenAI's competing agent. There are several youth lawsuits in the US this year, which management itself says may result in a material loss. Q3 results come 28/10.

Also in Software, cloud & internet

The highest scores in the same industry.

Whole industry